Watch how cancer survivors struggle to resume a normal life
11 Apr 2016
On 31 March and 1 April 2016, EORTC held its 2nd Summit on Cancer Survivorship. You can now watch the presentations and panel discussions that addressed both societal and health issues that cancer survivors face to resume a normal life.
Thursday 31 March 2016 – Societal Aspects
- Welcome (F. Meunier)
- Keynote lecture: Current policies and perspectives on cancer survivors employment (B. Van Damme deputy Head of cabinet of Belgium’s Minister of Public health and Social affairs M. De Block)
- Keynote lecture: Cancer as inspiration: re-interpreting the “C” word”! (Sir P. Jonas)
Session 1: A newly discovered reality (Chairs: P. O’Donnell & R. Sullivan)
- Keynote lecture: Quantify the magnitude of long-term cancer survivors in Europe (A. Waldmann)
- Keynote lecture: Economic burden of cancer across the European Union and unemployment (R. Sullivan)
- Panel discussion: The awareness of the societal challenges faced by cancer survivors and the policy support in EU (J. Kelly, Chairs & Speakers of the Session)
Session 2: Accessibility to Job, insurance and mortgage (Chairs: I. Lebrocquy & R. Stupp)
- Keynote lecture: Build a life after cancer: Discrimination issues & answers (E. Van Laer)
- Panel discussion (Moderator: A. Jack): Job, Insurance, Mortgage (I. Klingmann, I. Kössler, M. Massart, S. Narbutas, N. Van den Cruyce, M. Vanden Wijngaert, M. Vermaerke, Chairs & Speakers of the Session)
Session 3: Specificities related to survivors of childhood and young adolescent cancer (Chairs: F. Baron & G. Vassal)
- Quality of survivorship, a major goal in the SIOPE strategic plan (G. Vassal)
- Childhood cancer survivors: Facts and needs (G. Vassal)
- Access to recommendations, follow up and care: the survivorship passport (S. Essiaf)
- Long-term follow-up studies: The EORTC Leukemia Group Experience (C. Piette)
- Panel discussion (Chairs & Speakers of the Session)
- Conclusion (F. Meunier)
Friday 1 April 2016 – Medical Aspects
Session 4: Lifestyle after cancer – How to intervene? (Chairs: E.C. Moser & S. Narbutas)
- A patient’s perspective of cancer survivorship (I. Verdonck-de Leeuw )
- Role (early) interventions, life style (J. Maher)
- Growing up with cancer – Childhood cancer survivorship (C. Parsons)
- Panel discussion (Chairs & Speakers of the Session)
Session 5: Data collection and legal issues – Challenges (Chairs: J. Bogaerts & J. Reijneveld)
- Mobile, social and tech are disrupting healthcare. Get ready! (V. Keunen)
- Innovation radiotherapy data collection (P. Meijnders)
- European legal framework on collection and sharing of data (M. Verlinden)
- Panel discussion (L. Van Eycken, Chairs & Speakers of the Session)
Session 6: Lifestyle after cancer – How to measure? (Chairs: G. Katz & L. van de Poll-Franse)
- Infertility and sexuality after cancer treatment (R. Nout)
- 10 million cancer survivors in Europe (L. van de Poll-Franse)
- How to measure cognitive changes following cancer & cancer treatment? (S. Schagen)
- Is germline engineering acceptable for cancer survivors? (G. Katz)
- Panel discussion (P. Hoogendoorn, Chairs & Speakers of the Session)
Session 7: The EORTC survivorship taskforce, the commitment, vision and future perspectives (Chairs: L. Liu & A. Waldmann)
- Patient voice (B. Roman)
- The EORTC survivorship taskforce (L. Liu)
- Boost no-Boost trial: 20 years of follow-up of Breast Cancer (E.C. Moser)
- Panel discussion (Chairs & Speakers of the Session)
Related News
Professor Benjamin Besse becomes President of EORTC
26 Jun 2026
CCTG, EORTC and UK3CR welcome G7 commitment to accelerate global progress against cancer
24 Jun 2026
EORTC welcomes EU Biotech Act and calls for refinements to enable patient-centred trials
24 Jun 2026
New study confirms a key quality of life tool can be used with adolescents with cancer
9 Jun 2026
“Changing practice, improving lives”: EORTC publishes its Annual Report 2025
8 Jun 2026
This Clinical Trials Day, EORTC announces the upcoming Summit for Clinical Cancer Research
20 May 2026
Long-term EORTC trial challenges assumptions about lymph node radiation therapy in breast cancer
17 May 2026
Multinational study provides new evidence for the value of response-adapted, personalised treatment in Hodgkin lymphoma
1 May 2026
EORTC’s presence at ESTRO 2026
30 Apr 2026
Independent, academic cancer trials are vital to improve patient outcomes worldwide
28 Apr 2026
